AVM is a development-stage biotech company advancing the research, development and commercialization of game-changing stem cell technologies for high unmet medical needs in regenerative medicine, cancer treatment recovery, safer iPS cell culturing and treatment, and fully human biologics, including... Read more
View all
Pathotrak
College Park, United States · Grant
Clarametyx Biosciences, Inc.
Columbus, United States · Seed
Strand Therapeutics
Cambridge, United States · Series A
GID
Louisville, United States · Grant
SQZ Biotech
Watertown, United States · IPO
Spero Therapeutics
Cambridge, United States · Post IPO Equity
Quanterix
Billerica, United States · IPO
Caladrius Biosciences
Basking Ridge, United States · IPO
Moderna Therapeutics
Cambridge, United States · Post IPO Equity
Artax Biopharma
Cambridge, United States · Venture
Synthetic Genomics
San Diego, United States · Grant
Atomwise
San Francisco, United States · Grant